You are here

Optimizing treatment for any symptomatic heart failure with reduced ejection fraction patients.

John McMurray (UK)

John McMurray discusses that, while factors limiting treatment titration may vary between therapies and change over time, persistence and re-challenge are essential for treatment optimization in HFrEF patients.


This site is sponsored by:

Search this site


Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre.